Skip to content

Peer Coaching Intervention in Young Adults With Congenital Heart Disease

Peer Coaching Adaptive Self-Management Interventions for Young Adults With Congenital Heart Disease

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04271358
Acronym
CHASM in ACHD
Enrollment
33
Registered
2020-02-17
Start date
2020-10-08
Completion date
2032-03-02
Last updated
2026-06-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Congenital Heart Defect, Congenital Heart Disease

Brief summary

The purpose of the study is to evaluate a peer coaching intervention in young adults with congenital heart disease.

Detailed description

Our research team has developed a peer coaching intervention that has been deployed to promote activated self-management for AYAs with several conditions, and this has been modified adolescents and young adults (AYA) with with congenital heart disease (CHD). This study will be conducted over two years and pair AYA with CHD with a peer coach who also has CHD has successfully navigated the transition to adult medical care and over six months will work to promote the motivation for self-care as well as the development of self-management skills. This pilot study will test feasibility and acceptability, as well as preliminary efficacy and long-term effects on successful transfer to adult cardiology.

Interventions

The Peer Coaching group will receive 6 months of peer health coaching via a secure telephone and text messaging system.

Sponsors

Duke University
Lead SponsorOTHER
Adult Congenital Heart Association
CollaboratorUNKNOWN

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Intervention model description

Once enrolled, participants will be randomly assigned to the intervention or control group (1:1 ratio)

Eligibility

Sex/Gender
ALL
Age
18 Years to 26 Years
Healthy volunteers
No

Inclusion criteria

* Age 18-26 * Diagnosis of congenital heart disease * Patient at a Duke pediatric cardiology clinic * Access to a smart phone

Exclusion criteria

* Cognitive delay * Patient at an adult cardiology clinic

Design outcomes

Primary

MeasureTime frameDescription
Evaluate number of participants enrolledUp to 2 months after recruitment closesEvaluate the number of participants contacted about the study who actually enrolled
Evaluate completion of studyUp to 8 months after enrollment of each participantDetermine the number of participants who enrolled in the study who completed it
Measure impact on healthUp to 8 months after enrollment of each participantEvaluate the number of participant who stated the intervention had a positive impact on their health
Determine change in patient activationbaseline, 3 months, 6 monthsDetermine change in patient activation as measured by changes over time on the Patient Activation Measure (PAM)
Determine change in self-managementbaseline, 3 months, 6 monthsDetermine change in self-management as measured by changes over time in the Partners in health Scale (PIH)

Secondary

MeasureTime frameDescription
Determine change in transition readinessbaseline, 3 months, 6 monthsDetermine the change in transition readiness over 6 months as measured by the Transition Readiness Assessment Questionaire (TRAQ)
Determine change in health related quality of lifebaseline, 3 months, 6 monthsDetermine the change in health related quality of life over 6 months as measured by the Short-From 12 (SF-12)
Determine change in emotional healthbaseline, 3 months, 6 monthsDetermine the change in emotional health over 6 months as measured by the Brief Symptom Inventory (BSI)
Evaluate successful transfer of participants from pediatric to adult cardiology careup to 10 yearsEvaluate number of participants that transfer from pediatric to adult cardiology care with at least consecutive visits 10 years post study

Countries

United States

Contacts

PRINCIPAL_INVESTIGATORRichard A Krasuski, MD

Duke University

PRINCIPAL_INVESTIGATORGary Maslow, MD, MPH

Duke University

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jun 3, 2026